Canaccord analysts weighed in today on the tech giant Apple Inc. (NASDAQ:AAPL), chipmaker NVIDIA Corporation (NASDAQ:NVDA), and biotech AEterna Zentaris Inc.
In a research report released today, Canaccord Genuity analyst Neil Maruoka reiterated a Hold rating on shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) with a $0.
AEterna Zentaris Inc. (USA) (NASDAQ: AEZS), a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health, reported …
Aeterna Zentaris Inc. (USA) (NASDAQ:AEZS) and EMD Serono, Inc.
In a research report issued today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), with a $2.
H.C.
Canaccord Genuity analyst Neil Maruoka came out with a research note on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), reducing the price target to $0.
Maxim Group's healthcare analyst Jason Kolbert came out with a research note on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the company reported its fourth-quarter financial results and provided a corporate …
Chicago IL / Research Report Wire / February 27th, 2015 / Institutional Analyst Inc.(IA) announced today it released the its Top 20 Biotech …
In a research report sent to investors today, Maxim Group analyst Jason Kolbert maintained a Buy rating on Aeterna Zentaris (NASDAQ:AEZS) with a …
